Zapping the brain to calm dementia agitation
NCT ID NCT03846492
First seen Apr 14, 2026 · Last updated Jun 24, 2026 · Updated 7 times
Summary
This study explores how non-invasive brain stimulation can help understand and treat agitation in people with Alzheimer's and mixed dementia. Researchers will use transcranial magnetic stimulation (TMS) and electroencephalography (EEG) to study brain activity, and test whether transcranial direct current stimulation (tDCS) can reduce agitation. The study involves 90 participants, including those with and without agitation, plus healthy volunteers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEMENTIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre for Addiction and Mental Health
Toronto, Ontario, M6J 1H4, Canada
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
transcranial direct current stimulation (tDCS)
What this could lead to
If successful, this could point toward a safe, non-drug treatment for agitation in dementia, improving quality of life for patients and caregivers.
What could go wrong
This is an early-stage study focused on understanding brain mechanisms, not a proven treatment. The sample is small (90 people), and results may not apply to all dementia patients.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.